Preliminary studies reveal conolidine may possibly inhibit particular ion channels, lowering neuronal excitability and limiting suffering signals. This system is especially pertinent in neuropathic agony, where irregular signaling causes persistent soreness. Also, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness perception. Computational do... https://juvenalr581yws1.wikipowell.com/user